Healthcare Predictive Analytics Market Size To Reach $19.5 Billion By 2025: Grand View Research, Inc.

San Francisco, 6 September 2018; The global healthcarepredictive analytics market is expected to reach USD 19.5 billion by 2025, according to a new report by Grand View Research, Inc. Healthcare costs are increasing day by day and are anticipated to increase further. For instance, as per the IBM Global Business Services executive report in 2014, the per capita health expenditure of the U.S. was around USD 9,400 which was almost 2.4 times greater than the global average.

Government authorities, health organizations, and private players are striving to bring down health-care expenditure. Healthcare predictive analytics helps in bending the cost curve through optimization of the existing clinical workflow, operations, and payment strategies.

With the advent of IoT in health-care and wearable technology, people are more aware of the available health metrics monitoring platforms and choose to closely monitor health parameters. This phenomenon is generating huge amount of patient data inclusive of diet habits, physiological parameters, and vital signs. Predictive modeling based on this data helps in understanding disease patterns using statistical tools to draw an analysis of key therapy trends and outcomes.

Browse Research Report on Healthcare Predictive Analytics Market:

www.grandviewresearch.com/industry-analysis/healthcare-predictive-analytics-market

Further key findings from the study suggest:

·         Financial applications of healthcare predictive analytics held a significant share of around 30.0% in 2015. Revenue cycle management and fraud detection are key financial applications.

·         Increasing focus on population health management makes it one of the most lucrative growing application segments of the health-care predictive analytics market

·         Payers form the key end-user segment of this market. Various insurance companies, health plan sponsors, and third party payers are other users of predictive.

·         The usage of predictive analytics amongst payers such as hospitals, clinics, and physicians is anticipated to increase over the forecast period

·         North America, being a pioneer in health-care IT technologies, dominated the global health-care predictive analytics market. Available advanced infrastructure with ample resources contributed to its dominance.

·         Asia Pacific is expected to witness remunerative growth over the forecast period. Economic reforms, bolstering IT industry, and low operating costs are the key factors alluring market players to invest in this region.

·         Some of the key players in this space include IBM, Cerner Corporation, Verisk Analytics, Inc., McKesson Corporation, SAS, Oracle, Allscripts, Optum, Inc.and MedeAnalytics, Inc. New product launches and collaborations are the key strategic under takings amongst the sector participants.

View more reports of this category by Grand View Research at

www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the global healthcare predictive analytics market on the basis of application, end-use, and region:

Global Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Operations Management

o    Demand Forecasting

o    Workforce Planning and Scheduling

o    Inpatient Scheduling

o    Outpatient Scheduling

·         Financial

o    Revenue Cycle Management

o    Fraud Detection

o    Other Financial Applications

·         Population Health

o    Population Risk Management

o    Patient Engagement

o    Population Therapy Management

o    Other Applications

·         Clinical

o    Quality Benchmarking

o    Patient Care Enhancement

o    Clinical Outcome Analysis and Management

Global End-use Outlook (Revenue, USD Million, 2014 - 2025)

·         Healthcare Payers

·         Healthcare Providers

·         Other End-Users

View press release of this research report by Grand View Research:

www.grandviewresearch.com/press-release/global-healthcare-predictive-analytics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Gallium Nitride Semiconductor Devices Market Revenue Is To Reach A Value Of $4.3 Billion Forecast Till 2025: Grand View Research, Inc.

San Francisco, 6 September 2018;  According to a report published by Grand View Research, Inc.; the gallium nitride (GaN) semiconductor devices market is likely to reach a valuation of around USD 4.37 billion by 2025. Increasing demand in a variety of semiconductor devices and technological improvements in performance of GaN semiconductor devices can drive the market during the forecast period (from 2018 to 2025). Growing demand for energy-efficient power electronics, which use less power is projected to fuel market growth in the coming years. GaN-based semiconductors have dynamic mechanical and electrical properties such as saturation velocity and high-voltage breakdown. Thus, these semiconductors are extensively used in a varied range of switching devices.

The GaN-based semiconductors are also used in the defense industry due to their high thermal conductivity, high-temperature tolerance, and power density. Thus, rising expenditure on the defense sector in developed, as well as developing, countries is anticipated to boost the market growth in the coming years. Escalating demand for the Internet-of-Things (IoT) technology is also contributing toward the growth of the semiconductor devices as it offers several advantages including large electric filed, high breakdown voltage, and wider bandgap. These devices are also used in the healthcare industry in scanning equipment such as miniaturized x-ray machines MRI, and sonogram. This would further augment the market expansion in the years to come.

Browse Research Report on Gallium Nitride (GaN) Semiconductor Devices Market:

www.grandviewresearch.com/industry-analysis/gan-gallium-nitride-semiconductor-devices-market

Industry experts believe that GaN can serve as an alternative to silicon due its high efficiency and low power consumption competences. Therefore, it is considered as the most suitable material for manufacturing power electronic devices. In addition, GaN-based transistors offer benefits such as higher breakdown voltage with a wide ban, large electric field, and a high thermal conduction. These transistors are more efficient as compared to the silicon devices as they can be functional at high switch frequency and high-power density. The global gallium nitride (GaN) semiconductor devices market is segmented on the basis of product, wafer size, application, and region.

Based on product, the market is categorized into GaN radio frequency devices, power semiconductors, and opto-semiconductors. The GaN radio frequency devices sector is likely to grow at the maximum CAGR 20.4% from 2018 to 2025. On the basis of wafer size, the market is categorized into 2 inch, 4 inch, 6 inch, and 8 inch. The 6 inch wafer segment is expected to grow at the highest CAGR of 21.8 % from 2018 to 2025. On the basis of application, the market can be fragmented into automotive, consumer electronics, defense and aerospace, healthcare, information and communication technology, industrial and power, and others. The defense and aerospace sector is anticipated to register the maximum CAGR of 20.9 % during the forecast years.

Geographically, the market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the market in the pasta and valued at USD 322.5 million. Major expenses in the defense and aerospace industry for research and development is considered as the key driving factor for the region’s growth. The U.S. federal government is encouraging the implementation of energy-efficient devices, which is expected to create positive outlook for the market. For instance, government in the U.S. granted important contract to Raytheon Integrated Defense Systems to improve manufacturing of GaN semiconductor devices.

Asia Pacific is likely to witness the fastest growth in the coming years owing to high technological advancements resulting in a rise in the demand for high-performance RF components. The region is also expected to provide high growth opportunities for power electronics and optoelectronics devices. Some of the prominent companies operating in the gallium nitride (GaN) semiconductor devices market include Efficient Power Conversion Corporation, Inc.; GaN Systems, Inc.; Toshiba Corporation; and Fujitsu Ltd. These companies have undertaken strategic alliances and mergers and acquisitions as part of their market strategies and to develop advanced, more efficient GaN semiconductor devices.

For instance, Energous Corporation recently introduced a high-power, Near Field WattUp charging solution that features GaN-based 5-10W RF receiver IC and Power Amplifier (PA). It is designed for a variety of electronic devices including tablets, smartphones, smart speakers, drones, game controllers, and several others. The new product can charge devices with up to 10 watts of energy.

View press release of this research report by Grand View Research:

www.grandviewresearch.com/press-release/global-gan-gallium-nitride-semiconductor-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Foot & Ankle Devices Market Future Outlook To Reach $3.4 Billion By 2025: Grand View Research, Inc.

San Francisco, 6 September 2018; According to a report by Grand View Research, Inc., the global foot and ankle devicesmarket is estimated to reach at USD 3.4 billion by 2025. The market is anticipated to register a growth rate of 10.1 % during the forecast period (from 2018 to 2025). Growing cases of osteoporosis among geriatric population are anticipated to propel the demand for foot and ankle devices. These devices offer support and mobility during the recovery from injuries. Significant changes in skeletal and neurological systems among geriatric population leading to weak ligaments, arthritis, and Anterior Cruciate Ligament (ACL) tear can fuel the product demand in forthcoming years. Increasing number of sports-related injuries and road accidents are also expected to influence the market growth in the coming years.

Rising cases of diabetic foot ulcers, which can take longer time to heal is stimulating the demand for advanced healthcare systems and trauma devices. This is also anticipated to augment the market development from 2018 to 20025. Growing demand for these devices among athletes to prevent any possible injuries while performing is likely to propel market expansion. In addition, supportive reimbursement policies for joint replacement are also estimated to have a positive impact on the market growth in the next few years. Increasing adoption of surgeries related to ankle replacement attributed to ankle arthritis are expected to further augment the market demand during the forecast period.

Browse Research Report on Foot & Ankle Devices Market:

www.grandviewresearch.com/industry-analysis/foot-and-ankle-devices-market

The foot and ankle devices market is segregated on the basis of product, application, and region. On the basis of product, the market is categorized into joint implants, orthopedic fixation, bracing & support, soft tissue orthopedic devices, and prosthetics. Joint implants segment is anticipated to witness a substantial growth during the forecast period attributed to rising cases of implant surgeries among geriatric population. On the basis of application, the market is classified into trauma, hammertoe, osteoarthritis, rheumatoid arthritis, neurological disorders, bunions, and osteoporosis. In 2016, trauma segment dominated the market and accounted for revenue share equivalent to USD 263.3 million. It is expected to reach at USD 616.6 million by 2025.

On the basis of regions, the market is divided into Asia Pacific, North America, Europe, Latin America, and Middle East & Africa (MEA). In 2016, North America dominated the market and accounted for maximum revenue share. Growing number of geriatric population in the region is anticipated to be the major factor driving the region’s development. In addition, presence of advanced trauma centers established by local governments to handle emergency situations is also likely to stimulate the market growth in the region. Moreover, increasing number of diabetic patients suffering from foot ulcers can also influence the market demand in this region.

In Asia Pacific region, Japan is estimated to be the largest consumer of foot and ankle devices in the forthcoming years. Increasing number of road accidents coupled with growing geriatric population are likely to fuel the market growth in Asia Pacific. In addition, increasing cases of diabetes and osteoporosis can further impel the demand for effective trauma devices and healthcare systems in the region. This, in turn, can stimulate market growth during the forecast period.

Some of the leading companies in the foot and ankle devices market are Advanced Orthopedic Solutions; Zimmer Biomet; Stryker Corp.; Integra LifeSciences Corp.; and Bioretec Ltd. Most of these companies are investing more in R&D activities in order to introduce newer, cost-efficient, and advanced products. For instance, Nextremity Solutions recently received clearance from the US Food and Drug Administration (FDA) for its InCore Lapidus system. The device stabilizes and corrects multi-planar deformities. This joint is essential and lies at inner part of the middle of foot. When this joint faces excess movement or looseness, the condition is called hypermobility, which can further lead to formation of bunion. The fusion system can stabilize such deformity and provide visibility for surgeon’s joint preparation during Lapidus procedures.

  

View press release of this research report by Grand View Research:

www.grandviewresearch.com/press-release/global-foot-and-ankle-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Corporate Wellness Market Revenue Is To Reach A Value Of $84.9 Billion Forecast Till 2025: Grand View Research, Inc.

The global corporatewellness market size is expected to reach USD 84.9 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to expand at a CAGR of 6.8% during the forecast period. Rising demand for corporate wellness activities due to increased insurance costs that result in financial burden on employers is driving the market. The corporate wellness initiatives target particular health risk factors such as stress, obesity, smoking, diet, lack of exercise, etc.

Various companies across the globe have started initiating wellness programs for disease prevention and productivity improvement. According to a study conducted by Harvard economists, absenteeism costs fall by USD 2.73 for every dollar spent on wellness programs. Therefore, the employees need to be encouraged to adopt a healthier lifestyle to improve their productivity.

Browse Research Report on Corporate Wellness Market:

www.grandviewresearch.com/industry-analysis/corporate-wellness-market

Further key findings from the study suggest:

·         Corporate wellness programs are aiming at the improvement of employee well-being, to reduce absenteeism costs, which account for a huge productivity and monetary loss

·         In addition, employers have to pay the mandated health insurance costs, which increases their economic burden

·         Health risk assessment segment led the overall market, in terms of revenue share, in 2017. The health screening activities enable the employers to implement strategic initiatives to deal with the identified health risks

·         Stress management segment is likely to witness the fastest growth rate over the forecast period (from 2018 to 2025), owing to rising preference for on-site yoga and meditation services

·         Large-scale organizations dominated the end-use segment in 2017. Implementation of wellness services is easier and convenient in the large-scale companies due to their advanced infrastructure

·         Medium-scale organizations are likely to experience the fastest growth over the forecast period, due to increasing adoption of health screening services

·         Wellness service providers dominated the market in 2017. The fitness & nutrition consultants segment is anticipated to witness the fastest growth from 2018 to 2025

·         North America was the dominant regional market in 2017, in terms of revenue share

·         Asia Pacific is likely to have an impressive growth rate over the forecast periodon account of rapidly growing number of working individuals

·         Some of the key players in this market are ComPsych Corporation; Virgin Pulse, Inc.; Provant Health Solutions LLC; EXOS, Vitality Group, Inc.; Interactive Health, Inc.; Sodexo, FitLinxx, Inc.

View more reports of this category by Grand View Research at

www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the global corporate wellness market on the basis of service, end use, category, and region:

Corporate Wellness Service Outlook (Revenue, USD Million, 2014 - 2025)

·         Health Risk Assessment

·         Fitness

·         Smoking Cessation

·         Health Screening

·         Nutrition & Weight Management

·         Stress Management

·         Others

Corporate Wellness End Use Outlook (Revenue, USD Million, 2014 - 2025)

·         Small-scale Organizations

·         Medium-scale Organizations

·         Large-scale Organizations

View press release of this research report by Grand View Research:

www.grandviewresearch.com/press-release/global-corporate-wellness-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials, and healthcare.

For more information: www.grandviewresearch.com

Alzheimer’s Therapeutics Analysis Market Likely to Reach a Valuation of around USD 6.4 Billion in 2024: Grand view Research, Inc.

San Francisco September 6, 2018   The global alzheimer’s therapeutics market is expected to reach USD 6.4 billion in 2024, according to a new report by Grand View Research. Some primary factors driving the market growth includes rising government initiatives in order to raise awareness levels among people.

Growing knowledge about the Alzheimer’s disease (AD) and its high prevalence and incidence in developing economies are few of the major drivers supporting the market growth. Several governments, nonprofit, and private organizations worldwide are actively engaged in increasing people’s awareness regarding progressive AD, such as Alzheimer’s Association, the Alzheimer’s Society of Canada, Alzheimer’s Europe organization, and various other small organizations.

Furthermore, the increased government funding for providing better care and support to the people with partial dementia is another important factor anticipated to enlarge market growth. For instance, organizations like Florida Department of Health, the National Institute of Health, and Alzheimer’s Association in partnership with other private and government organizations provide funds to the research centers.

The presence of various pipeline drugs is anticipated to provide the market with potential growth opportunities. For instance, LMTX by TauRx Pharmaceutical Ltd.; idalopirdine (Lu AE58054) by Lundbeck; crenezumab by AC Immune SA; and BAN2401 by Eisai

Moreover, novel therapeutics with minimal dosage requirement has been introduced resulting in cost-effective alternatives, which is further expected to boost the market growth. For instance, Namzaric by Actavis was developed in two forms: 10 mg and 28 mg. 10 mg requires to be administered twice a day, while 28 mg requires to be administered once in a day.

Full Research Report On Alzheimer’s Therapeutics Market Analysis:
www.grandviewresearch.com/industry-analysis/alzheimers-therapeutics-market

Further Key Findings from the Study Suggest:

·         The cholinesterase inhibitors segment was dominant in 2013 but lost hold on the market till 2015. Patent expiry of key drugs such as Aricept, Exelon, and Razadyne was the major factor for decline in market share.

·         Exelon transdermal patch is estimated to lose exclusivity in 2019. It is a highly prescribed drug for the treatment of mild to moderate AD, which contributed toward its revenue generation in 2015.

·          N-methyl-D-aspartate receptor antagonist, on the other hand, is expected to witness a significant growth of around 16.0% over the forecast period owing to introduction of extended relase formulation of Namenda.

·         Other drug therapies such as monocloclonal antibodies and drugs targeting Tau proteins are in being studied in latter phases of the clinical trials. Presence of a strong of pipeline drugs for target disease are attributing toward fastest growth of these drugs

·         North America dominated the overall market in terms of revenue with share of over 33.0% in 2015, which is majorly facilitated by the availability of sophisticated healthcare facilities and infrastructure.

·         Some key players operating in this industry are Pfizer, Inc.; Merck & Co. Inc.; Novartis AG; Eisai Co. Ltd., H. Lundbeck A/S, AC Immune; TauRx Pharmaceuticals Ltd.; Actavis plc.; Forest Laboratories; and Teva Pharmaceuticals Industries Ltd.

·         Market players are expanding their product portfolio by developing and launching generic versions of drugs to sustain its market position. For instance, in 2015, Dr. Reddy’s Laboratories Ltd. and Mylan launched the generic version of Namenda (Forest laboratories – Actavis).

View More Reports Of This Category By Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Alzheimer’s therapeutics market on the basis of drug class and region:

Alzheimer’s Therapeutics Market Drug Outlook (Market Revenue in USD Million, 2013 - 2024)

·         Cholinesterase Inhibitors

·         N-methyl-D-aspartate (NMDA) receptor antagonist

Alzheimer’s Therapeutics Market Regional Outlook, (Market Revenue in USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

Access Full Press Release of this Report

www.grandviewresearch.com/press-release/global-alzheimers-therapeutics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/